Migayron et al. Front Immunol➜ DOI: 10.3389/fimmu.2024.1405215Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?This is an interesting review which approaches indirectly some of the paradoxical findings observed using targeted therapies in AD. Silverberg et al JAAD➜ DOI: 10.1016/j.jaad.2024.05.023Tapinarof Cream 1% Once Daily: Significant Efficacy in the Treatment of Moderate to Severe Atopic Dermatitis [...] Read More
Carmanius et al, JEADV 2024➜ DOI: 10.1111/jdv.20076A cross-sectional study based on the 24-year follow-up from the population-based birth cohort linked with dispensing data from the National Swedish Drug Register confirms that a large proportion of young adults with AD is undertreated or untreated. Kook et al, JEADV 2024➜ DOI: 10.1111/jdv.20053Misdiagnosis of AD or confounding skin diseases in [...] Read More
Federica Casetti, Cristina Has➜ First published: 03 March 2024 - DOI: 10.1111/ddg.15358Dupilumab improves congenital ichthyosis in the context of a filaggrin pathogenic variant. This report from Germany confirms other reports of a response of rare ichthyotic conditions such as Netherton’s syndrome and trichothiodystrophy to targeting IL-4Rα, and that the common FLG mutations may accentuate the inflammatory phenotype [...] Read More
Docampo-Simon et al Int J Dermatol 2024➜ First published: 03 March 2024 - DOI: 10.1111/ijd.17100Spanish investigators delineate based on a small case series psoriasis dermatitis, a common ambiguous phenotype of early forms of both psoriasis and atopic dermatitis in children; this phenotype was already well recognized in infants, but this study adds arguments for a later [...] Read More
Omatsu et al, Allergol Int 2024➜ PMID: 38310042. - DOI: 10.1016/j.alit.2024.01.008An interesting study from Japan shows that AD is very significantly associated with the incidence of HSV keratitis, and that preexisting AD blepharitis is an important contributing factor.This paper is important in the context of real or supposed AD co-morbidities where ophthalmologic comorbidities are generally not adequately [...] Read More
Vol. 103 (2023): Supplement 226. Immediate open access Please get your copy (authors retain copyright): https://doi.org/10.2340/actadv.v103.18470 About ActaDV Acta Dermato-Venereologica publishes high-quality manuscripts in the field of Dermatology and Venereology, dealing with new observations on basic dermatological and venereological research, as well as clinical investigations. Each volume features a number of Original articles in special […]
Read More
JEADV Patient-centered medicine in AD was highlighted last month by the JEADV clinical practice patient page summarizing the International Meeting of the Eczema Foundation which took place in Malta from 15 to 18 June 2022. It gathered 150 attendants from 25 countries and 5 continents. Patients, doctors, nurses and caregivers discussed and shared their experiences. This meeting addressed the […]
Read MoreVol. 102 (2022): Supplement 223. Immediate open access Please get your copy (authors retain copyright): About ActaDV Acta Dermato-Venereologica publishes high-quality manuscripts in the field of Dermatology and Venereology, dealing with new observations on basic dermatological and venereological research, as well as clinical investigations. Each volume features a number of Original articles in special areas, […]
Read More
The two founding papers of the SCORAD index are now in free access. Thanks to Prof. Jean-François STALDER who led the negotiations with Karger. Severity Scoring of Atopic Dermatitis: The SCORAD Index ➜ Consensus Report of the European Task Force on Atopic Dermatology1993;186:23–31. Nantes & Bordeaux, FR Web of Science Citations: 1416 / In the […]
Read More
I would like to draw your attention to the recently published position paper of the ISAD/OPENED task force, with a focus on the management of itch and pain in AD. Itch is central to AD, and was designed as the cardinal symptom by Besnier in the XIXth century, at the time when AD was named […]
Read More